| Particulars |
|
|
|
| Company Name
| Concord Biotech Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
10.46 |
B.V. (₹) |
174.50 |
| Sales(₹ Cr.) |
1,200.09 |
NP (₹ Cr.) |
356.39 |
| NP Var% |
21.00 |
Div% |
875.00 |
| CPS(₹) |
39.30 |
EPS (₹) |
34.10 |
| Traded Value(₹ Lakhs) |
2,227.63 |
52 Week High |
2,452.00 |
| 52 Week Low |
1,100.00 |
Price BSE |
1,339.00 |
| Price NSE |
1,327.00 |
Market Capital (₹ Cr.) |
14,011.25 |
| P/C Ratio |
34.10 |
P/E Ratio |
39.30 |
| Price Vs.BV |
7.67 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
247.06 |
| NP(₹ Cr.) |
62.90 |
NP Var % |
-36.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
1,085.75 |
| OPM |
42.20 |
NP |
328.71 |
| NP Var% |
-2.20 |
EPS |
30.73 |
| PE |
43.58 |
|
|